NCT05182879

Brief Summary

Evaluate the sensitivity of the GERONTOPOLE scale, used by general practitioners in primary care outpatients for the diagnosis of frailty in non-dependent people more than 65 years old, using as reference the "évaluation gériatrique standardisée clinique" (EGS)

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 12, 2019

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 10, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

6.9 years

First QC Date

December 22, 2021

Last Update Submit

May 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • assess the sensitivity of the GERONTOPOLE scale

    by practitionner

    2 years

Interventions

The practitionner assesses the frailty of the elderly outpatient with the GERONTOPOLE scale and compares it with the "évaluation gériatrique standardisée" (GDS)

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Elderly independent population

You may qualify if:

  • Independent patients

You may not qualify if:

  • Dependent outpatient, assessed with a "activity of daily living" (ADL) score \< 6/6

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Lille

Lille, Nord, 59000, France

Location

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Nassir MESSAADI, PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2021

First Posted

January 10, 2022

Study Start

February 12, 2019

Primary Completion

January 1, 2026

Study Completion

January 1, 2026

Last Updated

May 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations